🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Cerner (CERN) Earnings And Revenues Beat Estimates In Q4

Published 02/05/2020, 07:33 AM
Updated 07/09/2023, 06:31 AM
MSFT
-
COR
-
SYK
-
CERN
-
ARAY
-

Cerner Corporation (NASDAQ:CERN) reported fourth-quarter 2019 adjusted earnings of 75 cents per share, which beat the Zacks Consensus Estimate of 74 cents by 1.4%. The bottom line also improved from the prior-year quarter figure by 19%.

The company reported revenues of $1.44 billion, which improved 5.6% year over year and outpaced the Zacks Consensus Estimate by 0.6%.

Revenues by Geography

Per management, U.S. revenues grossed $1.28 billion, up 6% from the prior-year quarter.

Non-U.S. revenues increased 3% to $166 million from the year-ago quarter.

Bookings

In the reported quarter, the company’s bookings totaled $1.67 billion, down 15.1% from the year-ago quarter.

Segmental Performance

Licensed software revenues improved 4.8% to $174.5 million, driven by strong growth in SaaS offerings.

Technology resale revenues were $60.4 million, up 31.2% on a year-over-year basis.

Revenues from Subscriptions grossed $92.8 million, up 6.6% year over year.

Professional services’ revenues totaled $509.3 million, up 9.3% from the prior-year quarter number, on the back of solid growth in implementation services.

Revenues at the Managed services unit amounted to $309.4 million, up 3.5% from the prior-year quarter.

Support and maintenance revenues were $273.9 million, down 1% year over year.

Reimbursed travel revenues amounted to $21.9 million, reflecting a year-over-year decrease of 8.9%.

Cerner Corporation Price, Consensus and EPS Surprise

Cerner Corporation Price, Consensus and EPS Surprise

Cerner Corporation price-consensus-eps-surprise-chart | Cerner Corporation Quote

Margins

In the quarter under review, gross profit summed $1.16 billion, up 3.2% year over year. Gross margin was 80.8%, down 180 bps on a year-over-year basis.

General and administrative expenses increased 23.6% to $122.3 million. Further, software development expenses rose 3.7% to $188.2 million.

Adjusted operating margin expanded 160 bps to 20.3% during the reported quarter.

2020 Guidance

For the first quarter of 2020, Cerner expects revenues between $1.42 billion and $1.47 billion. The Zacks Consensus Estimate for revenues stands at $1.43 billion, within management’s guided range.

For the first-quarter 2020 adjusted earnings per share is projected between 69 cents and 71 cents.

New business bookings for first-quarter 2020 are estimated between $1.10 billion and $1.30 billion.

For the full-year 2020, the company anticipates revenues in the range of $5.72-$5.98 billion.

For the full year, adjusted earnings per share are expected between $3.09 and $3.19. The Zacks Consensus Estimate stands at $3.14, lies within the company’s guided range.

Wrapping Up

Cerner exited the fourth quarter on a strong note. The company continues to witness strong contributions from key areas like Population Health, Revenue Cycle and IT Works. Further, gains in Licensed software, Technology resale, Professional and Managed Services units buoy optimism. International revenues also moved up in the quarter.

The company benefited from electronic health record (EHR), electronic patient record (EPR) or electronic medical record (EMR) platforms that provide patient care in acute inpatient and outpatient settings.

Meanwhile, bookings witnessed a noticeable decline in the quarter under review. Contraction in operating margins remains a concern. Furthermore, competition in the global MedTech space is a woe.

Zacks Rank

Currently, Cerner carries a Zacks Rank #2 (Buy).

Earnings of Other MedTech Majors at a Glance

Some other top-ranked stocks which reported solid results this earning season are Stryker Corporation (NYSE:SYK) , Accuray Incorporated (NASDAQ:ARAY) and AmerisourceBergen Corporation (NYSE:ABC) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Stryker delivered fourth-quarter 2019 adjusted EPS of $2.49, outpacing the Zacks Consensus Estimate by 1.2%. Fourth-quarter reported revenues of $4.13 billion surpassed the Zacks Consensus Estimate by 0.7%. The company carries a Zacks Rank #2.

Accuray reported second-quarter fiscal 2020 adjusted earnings per share (EPS) of a penny, improving from the Zacks Consensus Estimate of a loss of 7 cents. Net revenues of $98.8 million outpaced the Zacks Consensus Estimate by 0.3%. The company sports a Zacks Rank #1.

AmerisourceBergen reported first-quarter fiscal 2020 adjusted EPS of $1.76, which beat the Zacks Consensus Estimate of $1.67 by 5.4%. The company has an expected long-term earnings growth rate of 7.4%. AmerisourceBergen carries a Zacks Rank of 2.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft (NASDAQ:MSFT) in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>



Cerner Corporation (CERN): Free Stock Analysis Report

Accuray Incorporated (ARAY): Free Stock Analysis Report

Stryker Corporation (SYK): Free Stock Analysis Report

AmerisourceBergen Corporation (ABC): Free Stock Analysis Report

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.